Apolipoprotein A1
Sign in to saveAlso known as epididymis secretory sperm binding protein, APOA1, apolipoprotein A-I, apo-AI
mammalian protein found in Homo sapiens
Protein · UniProt
Apolipoprotein A-I
- Gene
- APOA1
- Organism
- Homo sapiens (Human)
- Length
- 267 aa
- Molecular mass
- 30,778 Da
- Evidence
- 1: Evidence at protein level
Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility
3D-structureAmyloidAmyloidosisAtherosclerosisCholesterol metabolismDirect protein sequencingDisease variantGlycation
View on UniProt →
Swiss-Prot (reviewed) · via UniProt
Research
15,987 papers- High-Density Lipoproteins and Apolipoprotein A1.Sub-cellular biochemistry · 2020
- Apolipoprotein A1-Related Proteins and Reverse Cholesterol Transport in Antiatherosclerosis Therapy: Recent Progress and Future Perspectives.Cardiovascular therapeutics · 2022
- Apolipoprotein A1 and B.Clinics in laboratory medicine · 2006
- Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis.The Journal of clinical investigation · 2025
- Apolipoprotein-A1 transports and regulates MMP2 in the blood.Nature communications · 2025
via PubMed
Clinical Trials
27 registered- ACTIVE_NOT_RECRUITINGRelationship Between Serum Apolipoprotein Levels and Weight Loss in Patients Undergoing Sleeve Gastrectomy for Morbid ObesityYigit DUZKOYLU · NCT07325916
- PHASE4UNKNOWNCrossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)Oregon Health and Science University · NCT00736463
- NACOMPLETEDTheobromine, Vascular Function and Intestinal apoA-I ProductionMaastricht University Medical Center · NCT02209025
- NATERMINATEDMendelian Reverse Cholesterol Transport StudyUniversity of Pennsylvania · NCT01782027
- PHASE1/PHASE2COMPLETEDSafety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)Novartis · NCT00568594
- PHASE1RECRUITINGSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy VolunteersNational Heart, Lung, and Blood Institute (NHLBI) · NCT04216342